< Back to situations

[ORGANIZATION]

Perlmutter Cancer Center

Featured in 5 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS] [US] [AU] [CN]

Moderna and Merck melanoma vaccine clinical trials

19 clusters · 565 sources · last updated

Latest: Moderna and Merck melanoma vaccine shows 42% reduction in recurrence risk

Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon

[ACTIVE] [HEALTH] [DE] [US]

Pancreatic cancer research on resistance and evolution

2 clusters · 11 sources · last updated

Latest: Researchers identify new mechanisms in pancreatic cancer progression and resistance

Recent scientific studies have identified biological mechanisms that contribute to the aggressiveness and treatment resistance of pancreatic cancer. Research led by New York University, published in Nature Genetics, uti

[ACTIVE] [HEALTH] [US] [GR] [IT]

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ